A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed Refractory Multiple Myeloma
Clinical trial NCT03944057 · COMPLETED
Trial details
- NCT number
- NCT03944057
- Sponsor
- Antengene Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-02
- Primary completion
- 2022-02-25
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.